Increases criminal penalties for selling fetal tissue and requires documentation of costs associated with processing, transportation, and storage.
The bill is designed to tighten existing regulations surrounding the donation and sale of fetal tissue. Under current law, selling donated tissue is prohibited, but this bill enhances the legal ramifications for violations, which can serve as a deterrent against trafficking in fetal tissue. The requirement for detailed documentation adds a layer of accountability that could help ensure proper practices are followed. Additionally, the bill aims to uphold ethical standards in research involving human embryonic cells by emphasizing the importance of informed consent for individuals regarding the disposition of embryos.
Assembly Bill A307 proposes to increase penalties for the illegal sale of cadaveric fetal tissue, raising the crime from third degree to second degree. This legislative change seeks to impose stricter punishments, including up to ten years of imprisonment and fines as high as $300,000 for violations related to the sale of such tissue. The bill also mandates comprehensive tracking and documentation procedures for costs associated with the processing, transport, and storage of fetal tissue, ensuring that these procedures adhere to health and safety regulations.
While proponents of A307 argue that the bill protects both ethical standards in research and the rights of individuals, critics may see it as an overreach that could complicate legitimate biomedical research. There are concerns that the increased penalties may inadvertently hinder valuable research in medical advancements and stem cell therapies, as they could deter researchers from utilizing available fetal tissue for scientific purposes. The balance between protecting human dignity and promoting scientific research remains a contentious debate surrounding this legislation.